Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: A pilot randomized, sham-controlled clinical trial

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 7, 2009, Pages 745-753

  Lu, Weidong ^a,c   Matulonis, Ursula A ^a   Doherty Gilman, Anne ^a   Lee, Hang ^d   Dean Clower, Elizabeth ^a   Rosulek, Andrew ^a   Gibson, Carolyn ^d   Goodman, Annekathryn ^d   Davis, Roger B ^c   Buring, Julie E ^c   Wayne, Peter M ^b,c   Rosenthal, David S ^a   Penson, Richard T ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; PACLITAXEL; TOPOTECAN;

ACUPUNCTURE; ARTICLE; CANCER PATIENT; CHEMOTHERAPY INDUCED NEUTROPENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MANIPULATIVE MEDICINE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEUTROPHIL COUNT; OVARY CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; TREATMENT DURATION;

ACUPUNCTURE THERAPY; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPENIA; OVARIAN NEOPLASMS; PILOT PROJECTS;

EID: 67749088590     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0589     Document Type: Article

References (43)

1. Finberg RW, Talcott JA. Fever and neutropenia: How to use a new treatment strategy. NEJM 1999;341:362-363.
2. National Comprehensive Guidelines Network. Myeloid growth factors. Online document at: www.nccn.org; 2007. www.nccn.org/professionals/physician-gls/PDF/ myeloid- growth.pdf
3. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in nodepositive breast cancer: The results of 20 years of follow-up. NEJM 1995;332:901-906.
4. Matulonis U, Campos S, Duska L, et al. A phase ii trial of three sequential doublets for the treatment of advanced mullerian malignancies. Gynecol Oncol 2003;91:293-298.
5. Smith TJ, Khatcheressian J, Lyman GH, et al. 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006;24:3187-3205.
6. Papaldo P, Lopez M, Marolla P, et al. Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. J Clin Oncol 2005;23:6908-6918.
7. Touw IP, Bontenbal M. Granulocyte colony-stimulating factor: Key (f )actor or innocent bystander in the development of secondary myeloid malignancy? J Natl Cancer Inst 2007;99:183-186.
8. Hershman D, Neugut AI, Jacobson JS, et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 2007;99:196-205.
9. Zhang LZ, ed. The effect of acupuncture and moxibustion on blood system, 1 ed. New Edition Chinese Acupuncture and Moxibustion, 7. Shanghai: Shanghai Science and Technology Publishing House, 1992:947-949.
10. Zhou RX, Huang FL, Jiang SR, Jiang JC. Acupuncture effects on phagocytosis of white blood cells in human. Chin Acupuncture Moxibustion 1987;6:31-33.
11. Zhu X, Zhao HX, Liu H, Gan WM. Point block therapy for post-chemo leukopenia, 100 cases report. Chin Acupuncture Moxibustion 1995;15:3-4.
12. Lu W, Hu D, Dean-Clower E, et al. Acupuncture for chemotherapy-induced leukopenia: Exploratory meta-analysis of randomized controlled trials. J Soc Integr Oncol 2007;5: 1-10.
13. Yan DH. Effects of acupuncture and moxibustion on the contents and activity of serum colony stimulating factor (csf) in cyclophosphamide-treated mice. Zhen Ci Yan Jiu (Acupuncture Res) 1997;22:304-306.
14. Zhao XX, Wang HP, Tian KY, Huang XM. Effect of acupuncture and moxibustion on dynamic changes of bone marrow granulocyte series in chemotherapy-treated mice. Chin Acupuncture Moxibustion 2000;20: 172-174.
15. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972;3:257-260.
16. Wayne PM, Krebs DE, Macklin EA, et al. Acupuncture for upper-extremity rehabilitation in chronic stroke: A randomized sham-controlled study. Arch Phys Med Rehab 2005; 86:2248-2255.
17. Macklin EA, Wayne PM, Kalish LA, et al. Stop hypertension with the acupuncture research program (sharp): Results of a randomized, controlled clinical trial. Hypertension 2006;48: 838-845.
18. Yamamoto R, Kaneuchi M, Nishiya M, et al. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer. Cancer Chemother Pharmacol 2002;50:137-142.
19. Lu W, Dean-Clower E, Doherty-Gilman A, et al. Using exploratory meta-analysis to quantify acupuncture parameters: A novel approach in designing clinical trials. Proceedings of The Society for Integrative Oncology 2nd International Conference San Diego, California, 2005.
20. Cheng XN, ed. Chinese Acupuncture and Moxibustion, 2000 ed. Beijing: Foreign Languages Press, 2000.
21. Langevin HM, Churchill DL, Fox JR, et al. Biomechanical response to acupuncture needling in humans. J Appl Physiol 2001;91:2471-2478.
22. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0 (ctcae). Washington: National Cancer Institute, December 12, 2003.
23. Matulonis UA, Campos S, Krasner CN, et al. Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced mullerian malignancies: The modified triple doublet regimen. Gynecol Oncol 2006;103:575-580.
24. Hilpert F, du Bois A, Greimel ER, et al. Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/ paclitaxel in elderly patients aged > or=70 years with advanced ovarian cancer: A study by the AGO OVAR Germany. Ann Oncol 2007;18:282-287.
25. Lackner J, Lackner F, Semsroth M. Observations on the course of leucocytes in cardiac surgery under acupunctureanalgesia (author's transl). Anaesthesist 1976; 25(5): 246-47.
26. Lau BH, Wong DS, Slater JM. Effect of acupuncture on allergic rhinitis: Clinical and laboratory evaluations. Am J Chin Med (Gard City NY) 1975;3:263-70.
27. Ionescu-Tirgoviste C, Stroiescu F. Changes in eosinophils after acupuncture of the meridian of the liver. Stud Cercet Endocrinol 1968;19:405-411.
28. Kou W, Bell JD, Gareus I, et al. Repeated acupuncture treatment affects leukocyte circulation in healthy young male subjects: A randomized single-blind two-period crossover study. Brain Behav Immun 2005;19:318-324.
29. Lowenberg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. NEJM 2003;349:743-752.
30. Thomas X, Raffoux E, Botton S, et al. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: A trial by the acute leukemia french association (alfa) group. Leukemia 2007;21:453-461.
31. Janik JE, Miller LL, Korn EL, et al. A prospective randomized phase ii trial of gm-csf priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma. Blood 2001; 97:1942-1946.
32. Sun P, Zhou Y, Mao H, et al. Relationship between electro-acupuncture and spleen function on leukocyte. J Acupuncture Tuina Sci 2007;5: 336-340.
33. Akimoto T, Nakahori C, Aizawa K, et al. Acupuncture and responses of immunologic and endocrine markers during competition. Med Sci Sports Exerc 2003;35:1296-1302.
34. Melchart D, Ihbe-Heffinger A, Leps B, et al. Acupuncture and acupressure for the prevention of chemotherapy-induced nausea: A randomised cross-over pilot study. Support Care Cancer 2006;14: 878-882.
35. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced eme-sis: A randomized controlled trial. JAMA 2000;284:2755- 2761.
36. Reindl TK, Geilen W, Hartmann R, et al. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology: Interim results of a multicenter crossover study. Support Care Cancer 2006;14:172-176.
37. MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: The stricta recommendations. Complement Ther Med 2001; 9:246-249.
38. White AR, Filshie J, Cummings TM. Clinical trials of acupuncture: Consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med 2001;9:237-245.
39. Lundeberg T, Lund I. Are reviews based on sham acupuncture procedures in fibromyalgia syndrome (FMS) valid? Acupunct Med 2007; 25:100-106.
40. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:364-365.
41. Lund I, Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med 2006; 24:13-15.
42. Dhond RP, Kettner N, Napadow V. Do the neural correlates of acupuncture and placebo effects differ? Pain 2007;128:8-12.
43. Pariente J, White P, Frackowiak RS, Lewith G. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 2005;25:1161-1167.